NUDT1 and neoplasm: Moreover, as shown in Supplementary Table 2, a higher proportion of patients with high NUDT1 expression group show elevated AFP expression (≥ 200 ng/ml; 40% vs.), stage III-IV tumor stages (53% vs.), T3-T4 tumor size (56% vs.), G3-G4 tumor grades (47% vs.), and a higher degree of vascular invasion (42% vs.)than the patients with low NUDT1 expression.